1363155-62-7

Basic information

• Product Name: (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate
• Synonyms: (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate
• CAS NO: 1363155-62-7
• Molecular Weight: 352.43
• Mol File: 1363155-62-7.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate(1363155-62-7)
• EPA Substance Registry System: (E)-methyl 2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoate(1363155-62-7)

Safety Data

• Hazardous Substances Data: 1363155-62-7(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 85738-96-1 E/Z-1-Brom-3-methyl-1-buten 
• 870-63-3 prenyl bromide 
• 70719-50-5 2-bromomethyl-4,6-dimethoxy-benzoic acid methyl ester 
• 6110-37-8 methyl 2,4-dimethoxy-6-methylbenzoate 
• 87402-84-4 (E)-2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 87402-84-4 (E)-2-hydroxy-4-methoxy-3-(3-methylbut-2-en-1-yl)-6-styrylbenzoic acid 
• 64095-60-9 (E)-3-methoxy-2-(3-methylbut-2-en-1-yl)-5-styrylphenol 

Relevant articles and documents

Directed C-H Bond Functionalization: A Unified Approach to Formal Syntheses of Amorfrutin A, Cajaninstilbene Acid, Hydrangenol, and Macrophyllol

Formal syntheses of natural products amorfrutin A, cajaninstilbene acid, hydrangenol, and macrophyllol have been accomplished on the basis of successive C-H bond functionalization of ready-stock benzoic acids. This concise strategy involves transition-metal-catalyzed directed C-H olefination, C-H hydroxylation, and acid-mediated C-H prenylation as key steps.

Diarylvinylene similar structure compound and its preparation method and application

The invention discloses a group of diarylethene structure similar compounds as well as a preparation method and application thereof. The provided compounds have a structure of a general formula I. Moreover, the invention further provides medicinal compositions containing the compounds serving as active ingredients. Researches discover that the compounds have pharmacological activities of resisting influenza viruses, Coxsackie B3 viruses, AIDS viruses, hepatitis B viruses, hepatitis C viruses and the like. Therefore, the invention further provides the application of the compounds and the medicinal compositions containing the compounds serving as active ingredients in preparation of anti-virus medicaments. The invention lays a foundation for deeply researching and developing the application of the compounds as clinical medicaments. The general formula I is as shown in the specification.

Novel cajaninstilbene acid derivatives as antibacterial agents

Discovery of novel antibacterial agents with new structural scaffolds that combat drug-resistant pathogens is an urgent task. Cajaninstilbene acid, which is isolated from pigeonpea leaves, has shown antibacterial activity. In this study, a series of cajaninstilbene acid derivatives were designed and synthesized. The antibacterial activities of these compounds against gram-negative and gram-positive bacteria, as well as nine strains of methicillin-resistant staphylococcus aureus (MRSA) bacteria are evaluated, and the related structure-activity relationships are discussed. Assays suggest that some of the synthetic cajaninstilbene acid derivatives exhibit potent antibacterial activity against gram-positive bacterial strains and MRSA. Among these compounds, 5b, 5c, 5j and 5k show better antibacterial activity than the positive control compounds. The results of MTT assays illustrate the low cytotoxicity of the active compounds.